TG Therapeutics, Inc.
TGTX
$42.54
-$0.60-1.39%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 86.23% | -54.35% | -61.42% | 15.93% | 31.68% |
| Total Receivables | 106.21% | 136.58% | 129.32% | 176.91% | 192.57% |
| Inventory | -18.21% | 13.70% | 73.56% | 91.03% | 102.99% |
| Prepaid Expenses | -- | -- | -- | -- | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 152.40% | 266.38% | 71.14% | 260.07% | 151.88% |
| Total Current Assets | 68.65% | 11.37% | 4.48% | 70.62% | 78.74% |
|
|
|||||
| Total Current Assets | 68.65% | 11.37% | 4.48% | 70.62% | 78.74% |
| Net Property, Plant & Equipment | -6.44% | -12.21% | -12.28% | -12.33% | -13.11% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 11,076.35% | 10,785.97% | 10,753.65% | -3.02% | 26.18% |
| Total Assets | 132.81% | 84.05% | 74.91% | 75.12% | 75.90% |
|
|
|||||
| Total Accounts Payable | -26.20% | 26.77% | -19.96% | 20.38% | 29.84% |
| Total Accrued Expenses | 664.46% | 170.33% | 48.87% | 67.06% | 42.72% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -8.44% | -4.68% | 53.70% | 12.69% | 16.72% |
| Total Finance Division Other Current Liabilities | 29.59% | 75.22% | 112.74% | 153.38% | 167.93% |
| Total Other Current Liabilities | 29.59% | 75.22% | 112.74% | 153.38% | 167.93% |
| Total Current Liabilities | 16.79% | 69.57% | 25.33% | 58.18% | 60.72% |
|
|
|||||
| Total Current Liabilities | 16.79% | 69.57% | 25.33% | 58.18% | 60.72% |
| Long-Term Debt | 204.47% | 0.50% | 0.48% | 138.97% | 141.53% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -16.09% | -13.67% | -13.20% | -12.73% | -12.28% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 4.02% | -27.12% | -48.36% | -55.46% | 103.39% |
| Total Liabilities | 125.49% | 16.86% | 6.08% | 90.57% | 96.70% |
|
|
|||||
| Common Stock & APIC | 3.89% | 3.96% | 3.75% | 3.47% | 5.41% |
| Retained Earnings | 30.31% | 29.24% | 28.82% | 3.88% | 0.06% |
| Treasury Stock & Other | -1,224.51% | -1,014.45% | -4,106.21% | -9,298.29% | -6,360.26% |
| Total Common Equity | 145.75% | 191.42% | 216.00% | 55.68% | 48.20% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 145.75% | 191.42% | 216.00% | 55.68% | 48.20% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 145.75% | 191.42% | 216.00% | 55.68% | 48.20% |
|
|
|||||